It has been shown that LCN2 is upregulated during obesity and diabetes as a protective mechanism to counteract obesity-induced glucose intolerance by decreasing food intake and promoting adaptive β-cell proliferation (42). The gene discussed is LCN2; the disease is obesity disorder.